1. Home
  2. PCF vs NOTV Comparison

PCF vs NOTV Comparison

Compare PCF & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCF
  • NOTV
  • Stock Information
  • Founded
  • PCF 1987
  • NOTV 1974
  • Country
  • PCF United States
  • NOTV United States
  • Employees
  • PCF N/A
  • NOTV N/A
  • Industry
  • PCF Trusts Except Educational Religious and Charitable
  • NOTV Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCF Finance
  • NOTV Health Care
  • Exchange
  • PCF Nasdaq
  • NOTV Nasdaq
  • Market Cap
  • PCF 118.8M
  • NOTV 137.5M
  • IPO Year
  • PCF N/A
  • NOTV 1997
  • Fundamental
  • Price
  • PCF $6.34
  • NOTV $1.82
  • Analyst Decision
  • PCF
  • NOTV Strong Buy
  • Analyst Count
  • PCF 0
  • NOTV 1
  • Target Price
  • PCF N/A
  • NOTV $5.00
  • AVG Volume (30 Days)
  • PCF 74.8K
  • NOTV 914.8K
  • Earning Date
  • PCF 01-01-0001
  • NOTV 08-07-2025
  • Dividend Yield
  • PCF 10.90%
  • NOTV N/A
  • EPS Growth
  • PCF N/A
  • NOTV N/A
  • EPS
  • PCF N/A
  • NOTV N/A
  • Revenue
  • PCF N/A
  • NOTV $480,402,000.00
  • Revenue This Year
  • PCF N/A
  • NOTV $4.99
  • Revenue Next Year
  • PCF N/A
  • NOTV $5.39
  • P/E Ratio
  • PCF N/A
  • NOTV N/A
  • Revenue Growth
  • PCF N/A
  • NOTV N/A
  • 52 Week Low
  • PCF $5.71
  • NOTV $1.15
  • 52 Week High
  • PCF $6.96
  • NOTV $6.48
  • Technical
  • Relative Strength Index (RSI)
  • PCF 53.42
  • NOTV 39.87
  • Support Level
  • PCF $6.34
  • NOTV $1.86
  • Resistance Level
  • PCF $6.38
  • NOTV $3.19
  • Average True Range (ATR)
  • PCF 0.04
  • NOTV 0.31
  • MACD
  • PCF 0.00
  • NOTV -0.09
  • Stochastic Oscillator
  • PCF 60.00
  • NOTV 5.48

About PCF High Income Securities Fund

High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: